Persones / Equip Humà

Anna Planavila Porta

Buscador de publicacions

Publicacions

  • Palomer FX, Román-Azcona MS, Pizarro J, Planavila A, Villarroya-Gombau F, Valenzuela-Alcaraz BI, Crispi F, Sepúlveda-Martínez Á, Miguel-Escalada I, Ferrer J, Nistal JF, García R, Davidson MM, Barroso E and Vazquez M.

    SIRT3-mediated inhibition of FOS through histone H3 deacetylation prevents cardiac fibrosis and inflammation.

    signal transduction and targeted therapy . 5(1): 14-14. Nº de cites: 145

    [doi:10.1038/s41392-020-0114-1]

  • Ferrer-Curriu G, Redondo-Angulo I, Guitart-Mampel M, Ruperez C, Mas-Stachurska A, Sitges M, Garrabou G, Villarroya-Gombau F, Fernández-Solà J and Planavila A.

    Fibroblast growth factor-21 protects against fibrosis in hypertensive heart disease.

    JOURNAL OF PATHOLOGY . 248(1): 30-40. Nº de cites: 45

    [doi:10.1002/path.5226]

  • Rupérez CH, Lerin C, Ferrer-Curriu G, Cairo M, Mas-Stachurska A, Sitges M, Villarroya-Terrade J, Giralt M, Villarroya-Gombau F and Planavila A.

    Autophagic control of cardiac steatosis through FGF21 in obesity-associated cardiomyopathy

    INTERNATIONAL JOURNAL OF CARDIOLOGY . 260: 163-170. Nº de cites: 43

    [doi:10.1016/j.ijcard.2018.02.109]

  • Pellitero S, Piquer-Garcia I, Ferrer-Curriu G, Puig R, Martínez E, Moreno P, Tarascó J, Balibrea J, Lerin C, Puig-Domingo M, Villarroya-Gombau F, Planavila A and Sánchez-Infantes D.

    Opposite changes in meteorin-like and oncostatin m levels are associated with metabolic improvements after bariatric surgery

    INTERNATIONAL JOURNAL OF OBESITY . 42(4): 919-922. Nº de cites: 44

    [doi:10.1038/ijo.2017.268]

  • Redondo-Angulo I, Mas-Stachurska A, Sitges M, Tinahones FJ, Giralt M, Villarroya-Gombau F and Planavila A.

    Fgf21 is required for cardiac remodeling in pregnancy.

    CARDIOVASCULAR RESEARCH . 113(13): 1574-1584. Nº de cites: 34

    [doi:10.1093/cvr/cvx088]

  • Planavila A, Fernández-Solà J and Villarroya-Gombau F.

    Cardiokines as Modulators of Stress-Induced Cardiac Disorders.

    Advances In Protein Chemistry And Structural Biology . 108: 227-256. Nº de cites: 27

    [doi:10.1016/bs.apcsb.2017.01.002]

  • Quesada T, Cereijo R, Turatsinze JV, Planavila A, Cairo M, Gavaldà-Navarro A, Peyrou M, Moure R, Iglesias R, Giralt M, Eizirik DL and Villarroya-Gombau F.

    The lipid sensor GPR120 promotes brown fat activation and FGF21 release from adipocytes.

    NATURE COMMUNICATIONS . 7: 13479-13479. Nº de cites: 199

    [doi:10.1038/ncomms13479]

  • Redondo-Angulo I, Mas-Stachurska A, Sitges M, Giralt M, Villarroya-Gombau F and Planavila A.

    C/EBPß is required in pregnancy-induced cardiac hypertrophy.

    INTERNATIONAL JOURNAL OF CARDIOLOGY . 202: 819-828. Nº de cites: 12

    [doi:10.1016/j.ijcard.2015.10.005]

  • Villarroya-Terrade J, Redondo-Angulo I, Iglesias R, Giralt M, Villarroya-Gombau F and Planavila A.

    Sirt1 mediates the effects of a short-term high-fat diet on the heart.

    JOURNAL OF NUTRITIONAL BIOCHEMISTRY . 26(11): 1328-1337. Nº de cites: 13

    [doi:10.1016/j.jnutbio.2015.07.029]

  • Planavila A, Redondo-Angulo I and Villarroya-Gombau F.

    FGF21 and Cardiac Physiopathology.

    Frontiers in Endocrinology . 6: 133-133. Nº de cites: 87

    [doi:10.3389/fendo.2015.00133]